Mereo BioPharma (MREO) Treasury Shares (2018 - 2026)

Mereo BioPharma (MREO) has 6 years of Treasury Shares data on file, last reported at $1.2 million in Q4 2023.

• Treasury Shares for Q4 2023 came in at $1.2 million, down 0.88% year-over-year; the trailing twelve-month figure through Dec 2023 was $1.2 million (down 0.88% YoY), and the FY2023 annual result was $1.2 million, down 7.87% from the prior year.
• Treasury Shares slipped to $1.2 million in Q4 2023 per MREO's latest filing, from $1.2 million in the prior quarter.
• Over five years, Treasury Shares peaked at $1.6 million in Q1 2026 and troughed at $408230.7 in Q4 2022.
• A 5-year average of $908015.5 and a median of $923400.0 in 2023 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2019 and 2022: Treasury Shares surged 324.74% in 2019, then decreased 19.25% in 2022.
• A 5-year view of Treasury Shares shows it stood at $1.7 million in 2019, then grew by 2.7% to $1.7 million in 2020, then declined by 10.82% to $1.5 million in 2021, then decreased by 19.25% to $1.2 million in 2022, then dropped by 0.88% to $1.2 million in 2023.
• Business Quant data shows MREO's Treasury Shares at $1.2 million in Q4 2023, $1.2 million in Q4 2022, and $1.5 million in Q4 2021.